BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20424233)

  • 1. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.
    German JP; Wisse BE; Thaler JP; Oh-I S; Sarruf DA; Ogimoto K; Kaiyala KJ; Fischer JD; Matsen ME; Taborsky GJ; Schwartz MW; Morton GJ
    Diabetes; 2010 Jul; 59(7):1626-34. PubMed ID: 20424233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
    Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
    Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling.
    Denroche HC; Levi J; Wideman RD; Sequeira RM; Huynh FK; Covey SD; Kieffer TJ
    Diabetes; 2011 May; 60(5):1414-23. PubMed ID: 21464443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms.
    Li X; Wu X; Camacho R; Schwartz GJ; LeRoith D
    PLoS One; 2011 Feb; 6(2):e17058. PubMed ID: 21379576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet.
    Kusakabe T; Tanioka H; Ebihara K; Hirata M; Miyamoto L; Miyanaga F; Hige H; Aotani D; Fujisawa T; Masuzaki H; Hosoda K; Nakao K
    Diabetologia; 2009 Apr; 52(4):675-83. PubMed ID: 19169663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats.
    Hidaka S; Yoshimatsu H; Kondou S; Tsuruta Y; Oka K; Noguchi H; Okamoto K; Sakino H; Teshima Y; Okeda T; Sakata T
    FASEB J; 2002 Apr; 16(6):509-18. PubMed ID: 11919153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lavatera critica controls systemic insulin resistance by ameliorating adipose tissue inflammation and oxidative stress using bioactive compounds identified by GC-MS.
    Veeramani C; Alsaif MA; Al-Numair KS
    Biomed Pharmacother; 2018 Oct; 106():183-191. PubMed ID: 29958142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.
    Park S; Kim DS; Kwon DY; Yang HJ
    J Neuroendocrinol; 2011 Aug; 23(8):687-98. PubMed ID: 21599766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.
    Zouhar P; Rakipovski G; Bokhari MH; Busby O; Paulsson JF; Conde-Frieboes KW; Fels JJ; Raun K; Andersen B; Cannon B; Nedergaard J
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E72-E86. PubMed ID: 31743040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.
    Meek TH; Dorfman MD; Matsen ME; Fischer JD; Cubelo A; Kumar MR; Taborsky GJ; Morton GJ
    Diabetes; 2015 Jul; 64(7):2376-87. PubMed ID: 25633417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic disorders and adipose tissue insulin responsiveness in neonatally STZ-induced diabetic rats are improved by long-term melatonin treatment.
    de Oliveira AC; Andreotti S; Farias Tda S; Torres-Leal FL; de Proença AR; Campaña AB; de Souza AH; Sertié RA; Carpinelli AR; Cipolla-Neto J; Lima FB
    Endocrinology; 2012 May; 153(5):2178-88. PubMed ID: 22374967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
    Sindelar DK; Havel PJ; Seeley RJ; Wilkinson CW; Woods SC; Schwartz MW
    Diabetes; 1999 Jun; 48(6):1275-80. PubMed ID: 10342816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma leptin in diabetic and insulin-treated diabetic and normal rats.
    Sivitz WI; Walsh S; Morgan D; Donohoue P; Haynes W; Leibel RL
    Metabolism; 1998 May; 47(5):584-91. PubMed ID: 9591751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats.
    Akirav EM; Chan O; Inouye K; Riddell MC; Matthews SG; Vranic M
    Metabolism; 2004 Dec; 53(12):1558-64. PubMed ID: 15562400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia.
    German JP; Thaler JP; Wisse BE; Oh-I S; Sarruf DA; Matsen ME; Fischer JD; Taborsky GJ; Schwartz MW; Morton GJ
    Endocrinology; 2011 Feb; 152(2):394-404. PubMed ID: 21159853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.
    Feigh M; Hjuler ST; Andreassen KV; Gydesen S; Ottosen I; Henriksen JE; Beck-Nielsen H; Christiansen C; Karsdal MA; Henriksen K
    Eur J Pharmacol; 2014 Aug; 737():91-6. PubMed ID: 24858364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats.
    Cummings BP; Bettaieb A; Graham JL; Stanhope KL; Dill R; Morton GJ; Haj FG; Havel PJ
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14670-5. PubMed ID: 21873226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
    Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
    Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
    Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
    Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling.
    Park S; Hong SM; Sung SR; Jung HK
    Endocrinology; 2008 Feb; 149(2):445-54. PubMed ID: 17991727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.